Inspire Medical's Strong 2025 Outlook And Upcoming Inspire V Launch Earns Analyst Upgrade

BofA Securities has upgraded Inspire Medical Systems, Inc. INSP and says the company now falls in the profitable growth category.Inspire Medical is expected to give its 2025 revenue guidance in early January, likely alongside its fourth-quarter results.The company has already stated that it is comfortable with the Street’s consensus of $950 million in revenue for 2025.For 2024, the company expects sales of $793 million – $798 million compared to prior guidance of $788 million – $798 million and a consensus ...